Stocks to sell

It’s a good time to consider how your portfolio’s doing now that we’re halfway through 2024. While the S&P 500 and the Nasdaq composite both show gains more than16%, the Dow Jones Industrial Average lags with a gain of only 4% for the year. It’s time to look for F-rated stocks to sell. When you’re
Many methods offer exposure to the global electric vehicle market. Investing in China-based EV manufacturer Nio (NYSE:NIO) simply isn’t your best bet in 2024’s second half. NIO stock had a significant decline in the first half, receiving a “D” grade with little confidence. Sure, a miracle could happen during the remaining months of the year and Nio’s loyal investors
When it comes to stocks, valuation matters. The price-to-earnings (P/E) ratio measures a company’s share price relative to its earnings per share (EPS). The P/E ratio helps to determine if a stock is expensive, or trading at a high multiple, relative to its peers or the overall market. Currently, the average P/E ratio among stocks
The autonomous vehicle industry, characterized by its high-tech allure, is currently navigating through turbulent waters. Investors initially flocked to this sector, enchanted by the futuristic vision of self-driving cars and AI-driven efficiency gains. However, reality has started to set in, revealing significant challenges that include technological limitations, regulatory hurdles, and unexpected market dynamics. Autonomous driving
Although the Federal Reserve’s continued caution regarding interest rate cuts has stymied a further recovery for real estate investment trusts (REITs), when it comes to the top REITs to sell, that’s not the main issue at hand. Rather, these clear-cut sells in the sector face either REIT-specific or property class-specific headwinds. That is, there are
The tech sector witnessed record highs on Tuesday, driven by continued interest in companies focused on artificial intelligence (AI). However, there are concerns about overvalued stocks as investors show exuberance around certain companies’ prospects. Recent equity index gains appear to stem primarily from a small number of large firms. Even typically bullish analysts covering the
Ask five analysts their perspective on a stock like Apple (NASDAQ:AAPL) or Tesla (NASDAQ:TSLA), and you’ll likely find five different answers. Look to the massive gap between Cathie Wood’s $2,600 Tesla price target and Pr Lekander’s $14 per-share pricing prediction for evidence of the wide disparity among analysts, even among popular and well-liked stocks. Analysts
The biotech segment is a relatively new sector that combines the fields of biology and technology. It integrates natural sciences from biology and engineering aspects from technology to develop products with meaningful applications in areas like medicine, agriculture, therapeutics, and more.  It possesses an astonishing Compounding Annual Growth Rate (CAGR) of 13.96% until 2030. However,